New therapies for advanced, recurrent, and metastatic endometrial cancers.
about
HOXB9 promotes endometrial cancer progression by targeting E2F3.Endophytic-Type Endometrial Cancer with Adenomyosis Successfully Diagnosed with Hysteroscopic Endometrial Biopsy Using an 8.3-mm Operative Resectoscope: A Case Report.Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells
P2860
New therapies for advanced, recurrent, and metastatic endometrial cancers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
New therapies for advanced, recurrent, and metastatic endometrial cancers.
@en
New therapies for advanced, recurrent, and metastatic endometrial cancers.
@nl
type
label
New therapies for advanced, recurrent, and metastatic endometrial cancers.
@en
New therapies for advanced, recurrent, and metastatic endometrial cancers.
@nl
prefLabel
New therapies for advanced, recurrent, and metastatic endometrial cancers.
@en
New therapies for advanced, recurrent, and metastatic endometrial cancers.
@nl
P2093
P2860
P1476
New therapies for advanced, recurrent, and metastatic endometrial cancers
@en
P2093
Angela K Green
Brittany Davidson
David Mutch
Robert M Wenham
Vicky Makker
P2860
P2888
P356
10.1186/S40661-017-0056-7
P577
2017-12-02T00:00:00Z
P6179
1093116427